Lee Middleton

ORCID: 0000-0003-4621-1922 · 18 papers in corpus · active 2007-2024

Study types

  • article 13
  • rct 3
  • review 2

Condition tags

  • chronic_pelvic_pain 9
  • endometriosis 6
  • dysmenorrhea 2
  • adenomyosis 2
  • endometrioma 1
  • dyspareunia 1
rct 2024
BMJ open ·doi:10.1136/bmjopen-2024-088072

OBJECTIVES: To evaluate the cost-effectiveness of long-acting progestogens (LAP), including levonorgestrel-releasing intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA), compared with the combined oral contraceptives …

article 2024
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2023-079006

Abstract Objectives To evaluate the clinical effectiveness of long acting progestogens compared with the combined oral contraceptive pill in preventing recurrence of endometriosis related pain. Design The PRE-EMPT (preventing recurrence of …

rct 2024
Health technology assessment (Winchester, England) ·doi:10.3310/SQWY6998

BACKGROUND: Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there is uncertainty about the best o…

rct 2022
Health technology assessment (Winchester, England) ·doi:10.3310/ZDEG6110

BACKGROUND: Uterine fibroids are the most common tumour in women of reproductive age and are associated with heavy menstrual bleeding, abdominal discomfort, subfertility and reduced quality of life. For women wishing to retain their uterus …

article 2021
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2021.100139

OBJECTIVE: To examine the quality of life experienced by women with symptomatic uterine fibroids who had been treated with UAE in comparison to myomectomy. We report the four-year follow-up of the FEMME randomised trial. Two-year follow-up …

article 2020
·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

article 2020

Background Chronic pelvic pain (CPP) affects 2-24% of women worldwide and evidence for medical treatments is limited. Gabapentin is effective in treating some chronic pain conditions. We aimed to determine the efficacy and safety of gabapen…

article 2018
·doi:10.60692/6nvwt-mjd92

Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is …

article 2018
·doi:10.1136/bmjopen-2016-014924

INTRODUCTION: Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and…

article 2018
Health technology assessment (Winchester, England) ·doi:10.3310/hta22400

Background Chronic pelvic pain (CPP) symptoms in women are variable and non-specific; establishing a differential diagnosis can be hard. A diagnostic laparoscopy is often performed, although a prior magnetic resonance imaging (MRI) scan may…

article 2017
·doi:10.6084/m9.figshare.4746715.v1

CONSORT flow diagram and Checklist. (DOCX 34 kb)

article 2017
·doi:10.6084/m9.figshare.4746715

CONSORT flow diagram and Checklist. (DOCX 34 kb)

article 2015
·doi:10.3310/hta19880

BACKGROUND: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. OBJECTIVES: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-relea…

article 2014
·doi:10.1371/journal.pone.0091891

OBJECTIVE: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and …

article 2013
·doi:10.1056/nejmoa1204724

BACKGROUND: Menorrhagia is a common problem, yet evidence to inform decisions about therapy is limited. In a pragmatic, multicenter, randomized trial, we compared the levonorgestrel-releasing intrauterine system (levonorgestrel-IUS) with us…

article 2011
·doi:10.1016/1056-8719(93)90055-j

According to the original receptor occupancy theory proposed by Clark in the 1930s, the percent occupancy of total available receptors by an agonist is linearly related to the response (or effect). However, the first recognition of "recepto…

review 2010
·doi:10.1093/humupd/dmq031

BACKGROUND: There have been conflicting results in randomized trials of the effects of laparoscopic uterosacral nerve ablation (LUNA) in chronic pelvic pain. Our objective was to perform a meta-analysis using individual patient data (IPD) t…

review 2007
·doi:10.1111/j.1471-0528.2007.01542.x

BACKGROUND: Currently, there are a number of clinical trials, but no international collaboration for collating research on effectiveness of laparoscopic uterosacral nerve ablation (LUNA) for alleviating chronic pelvic pain. OBJECTIVE: Meta-…